Ethnopharmacological relevance: Combretum racemosum showed activity in previous ethnopharmacological investigations of some Combretum species used in malaria treatment in parts of West Africa. Aim of the study: This study aimed at confirming the antimalarial potential of this plant by an activity-guided isolation of its active principles. Materials and methods: A crude methanolic leaf extract of Combretum racemosum and fractions thereof obtained by partition with chloroform and n-butanol were investigated for antiplasmodial activity against chloroquine-sensitive (D10) and chloroquine-resistant (W2) strains of Plasmodium falciparum. Repeated chromatographic separations were conducted on the chloroform fraction to isolate bioactive compounds for further tests on antiplasmodial activity. The characterization of the isolated substances was performed by applying NMR- and MS-techniques (ESI-MS, HR-ESIMS, 1D and 2D NMR). Results: The chloroform fraction (D10: IC50 = 33.8 ± 1.5 μg/mL and W2: IC50 = 27.8 ± 2.9 μg/mL) exhibited better antiplasmodial activity than the n-butanol fraction (D10: IC50 = 78.1 ± 7.3 μg/mL and W2: IC50 = 78 ± 15 μg/mL) as well as the methanolic raw extract (D10: IC50 = 64.2 ± 2.7 μg/mL and W2: IC50 = 65.8 ± 14.9 μg/mL). Thus, the focus of the phytochemical investigation was laid on the chloroform fraction, which led to the identification of four ursane-type (19α-hydroxyasiatic acid (1), 6β,23-dihydroxytormentic acid (4), madecassic acid (8), nigaichigoside F1 (10)) and four oleanane-type (arjungenin (2), combregenin (5), terminolic acid (7), arjunglucoside I (11)) triterpenes, as well as abscisic acid (9). Compounds 1 and 2, 4 and 5, 7 and 8 as well as 10 and 11 were isolated as isomeric mixtures in fractions CR-A, CR-C, CR-E and CR-H, respectively. All isolated compounds and mixtures exhibited moderate to low activity, with madecassic acid being most active (D10: IC50 = 28 ± 12 μg/mL and W2: IC50 = 17.2 ± 4.3 μg/mL). Conclusion: This paper reports for the first time antiplasmodial principles from C. racemosum and thereby gives reason to the traditional use of the plant.

Antiplasmodial activity of triterpenes isolated from the methanolic leaf extract of Combretum racemosum P. Beauv / W.M. Oluyemi, B.B. Samuel, H. Kaehlig, M. Zehl, S. Parapini, S. D'Alessandro, D. Taramelli, L. Krenn. - In: JOURNAL OF ETHNOPHARMACOLOGY. - ISSN 0378-8741. - 247(2020 Jan 30).

Antiplasmodial activity of triterpenes isolated from the methanolic leaf extract of Combretum racemosum P. Beauv

S. Parapini
Investigation
;
S. D'Alessandro
Investigation
;
D. Taramelli
Penultimo
Supervision
;
2020

Abstract

Ethnopharmacological relevance: Combretum racemosum showed activity in previous ethnopharmacological investigations of some Combretum species used in malaria treatment in parts of West Africa. Aim of the study: This study aimed at confirming the antimalarial potential of this plant by an activity-guided isolation of its active principles. Materials and methods: A crude methanolic leaf extract of Combretum racemosum and fractions thereof obtained by partition with chloroform and n-butanol were investigated for antiplasmodial activity against chloroquine-sensitive (D10) and chloroquine-resistant (W2) strains of Plasmodium falciparum. Repeated chromatographic separations were conducted on the chloroform fraction to isolate bioactive compounds for further tests on antiplasmodial activity. The characterization of the isolated substances was performed by applying NMR- and MS-techniques (ESI-MS, HR-ESIMS, 1D and 2D NMR). Results: The chloroform fraction (D10: IC50 = 33.8 ± 1.5 μg/mL and W2: IC50 = 27.8 ± 2.9 μg/mL) exhibited better antiplasmodial activity than the n-butanol fraction (D10: IC50 = 78.1 ± 7.3 μg/mL and W2: IC50 = 78 ± 15 μg/mL) as well as the methanolic raw extract (D10: IC50 = 64.2 ± 2.7 μg/mL and W2: IC50 = 65.8 ± 14.9 μg/mL). Thus, the focus of the phytochemical investigation was laid on the chloroform fraction, which led to the identification of four ursane-type (19α-hydroxyasiatic acid (1), 6β,23-dihydroxytormentic acid (4), madecassic acid (8), nigaichigoside F1 (10)) and four oleanane-type (arjungenin (2), combregenin (5), terminolic acid (7), arjunglucoside I (11)) triterpenes, as well as abscisic acid (9). Compounds 1 and 2, 4 and 5, 7 and 8 as well as 10 and 11 were isolated as isomeric mixtures in fractions CR-A, CR-C, CR-E and CR-H, respectively. All isolated compounds and mixtures exhibited moderate to low activity, with madecassic acid being most active (D10: IC50 = 28 ± 12 μg/mL and W2: IC50 = 17.2 ± 4.3 μg/mL). Conclusion: This paper reports for the first time antiplasmodial principles from C. racemosum and thereby gives reason to the traditional use of the plant.
English
Antiplasmodial activity; Combretum racemosum; Isolation; Madecassic acid; Triterpenes
Settore MED/04 - Patologia Generale
Settore MED/07 - Microbiologia e Microbiologia Clinica
Settore MED/46 - Scienze Tecniche di Medicina di Laboratorio
Articolo
Esperti anonimi
Ricerca di base
Pubblicazione scientifica
Goal 3: Good health and well-being for people
   Towards multi-stage drugs to fight poverty related and neglected parasitic diseases: synthetic and natural compounds directed against Leishmania, Plasmodium and Schistosoma life stages and assessment of their mechanisms of action.
   MINISTERO DELL'ISTRUZIONE E DEL MERITO
   20154JRJPP_004
30-gen-2020
Elsevier
247
112203
Pubblicato
Periodico con rilevanza internazionale
scopus
pubmed
crossref
datacite
Aderisco
info:eu-repo/semantics/article
Antiplasmodial activity of triterpenes isolated from the methanolic leaf extract of Combretum racemosum P. Beauv / W.M. Oluyemi, B.B. Samuel, H. Kaehlig, M. Zehl, S. Parapini, S. D'Alessandro, D. Taramelli, L. Krenn. - In: JOURNAL OF ETHNOPHARMACOLOGY. - ISSN 0378-8741. - 247(2020 Jan 30).
reserved
Prodotti della ricerca::01 - Articolo su periodico
8
262
Article (author)
si
W.M. Oluyemi, B.B. Samuel, H. Kaehlig, M. Zehl, S. Parapini, S. D'Alessandro, D. Taramelli, L. Krenn
File in questo prodotto:
File Dimensione Formato  
Oluyemi_2020.pdf

accesso riservato

Tipologia: Publisher's version/PDF
Dimensione 496.53 kB
Formato Adobe PDF
496.53 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/706587
Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 13
  • ???jsp.display-item.citation.isi??? 10
social impact